SEC Form 4 · accession 0001144204-15-013667

CorMedix Inc. · CRMD

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Mar 2, 2015

Accepted (ET)

Mar 3, 2015 · 5:02 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001410098

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock, $0.001 par value per share	holding	—	—		—	63,386	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (right to buy)^F3	$5.62	Mar 2, 2015	A	50,000	A	—	Mar 1, 2025	Common Stock, $0.001 par value per share	50,000	50,000	D
Stock Option (right to buy)^F1	$2.05	holding	—	—	—	—	Apr 3, 2024	Common Stock, $0.001 par value per share	30,000	30,000	D
Common Stock Warrants (right to buy)^F2	$0.90	holding	—	—	—	Jan 8, 2014	Jan 8, 2020	Common Stock, $0.001 par value per share	25,000	25,000	D

F1These shares vest 1/3 on date of grant, 1/3 on first anniversary of date of grant and 1/3 on second anniversary of date of grant.
F2On January 8, 2014, the reporting person acquired through a private placement, (i) 5,000 shares of the Company's Series C-3 Non-Voting Convertible Preferred Stock, each share convertible into 10 shares of Common Stock, $0.001 par value per share (and which were converted to common stock on October 29, 2014); and (ii) a five-year warrant to purchase common Stock at an exercise price of $1.25 per share. The Series C-3 Non-voting Convertible Preferred Stock and warrants were purchased together at a purchase price of $10.00 per share. The warrant exercise price was decreased to $0.90 per share effective September 15, 2014.
F3The options vest in full on the first anniversary of the date of grant.